<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30082387</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>13</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>13</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1091-6490</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>115</Volume>                    <Issue>33</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>08</Month>                        <Day>14</Day>                    </PubDate>                </JournalIssue>                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>            </Journal>            <ArticleTitle>Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>8236-8238</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1811263115</ELocationID>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Foulds</LastName>                    <ForeName>Charles E</ForeName>                    <Initials>CE</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX 77030; foulds@bcm.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016420">Comment</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>            <NlmUniqueID>7505876</NlmUniqueID>            <ISSNLinking>0027-8424</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2015 May;16(5):299-311</RefSource>                <PMID Version="1">25854182</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2015 Aug 06;107(10):null</RefSource>                <PMID Version="1">26251289</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2015 Sep;12(9):541-52</RefSource>                <PMID Version="1">26011489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2015 Oct;12(10):573-83</RefSource>                <PMID Version="1">26122181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2009 Sep;9(9):631-43</RefSource>                <PMID Version="1">19701242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2018 Feb 12;33(2):173-186.e5</RefSource>                <PMID Version="1">29438694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1997 Apr 1;57(7):1244-9</RefSource>                <PMID Version="1">9102207</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biol Sci. 2012;8(10):1385-97</RefSource>                <PMID Version="1">23139636</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2007 Apr 1;13(7):1950-4</RefSource>                <PMID Version="1">17404074</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2014 Jan 16;21(1):R31-49</RefSource>                <PMID Version="1">24434719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Sep 1;34(25):2961-8</RefSource>                <PMID Version="1">27269946</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2015 Mar 12;160(6):1246-60</RefSource>                <PMID Version="1">25748654</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2013 Dec 1;19(23):6389-97</RefSource>                <PMID Version="1">24298069</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2013 Jul 25;51(2):185-99</RefSource>                <PMID Version="1">23850489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2014 Jun;23(3):201-8</RefSource>                <PMID Version="1">24589524</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:220-34</RefSource>                <PMID Version="1">26455641</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Med. 2011;62:233-47</RefSource>                <PMID Version="1">20887199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2017 Oct;18(10):613-623</RefSource>                <PMID Version="1">28649135</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):7869-7878</RefSource>                <PMID Version="1">29987050</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="CommentOn">                <RefSource>Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):7869-7878</RefSource>                <PMID Version="1">29987050</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <CoiStatement>The author declares no conflict of interest.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>02</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30082387</ArticleId>            <ArticleId IdType="pii">1811263115</ArticleId>            <ArticleId IdType="doi">10.1073/pnas.1811263115</ArticleId>            <ArticleId IdType="pmc">PMC6099889</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>